Chlamydia trachomatis testing patterns and prevalence of genital chlamydial infection among young men and women in central Norway 1990-2003: A population-based registry study

Sexually Transmitted Diseases

Volumn 33, Issue 1, 2006, Pages 26-30

  Bakken, Inger Johanne ^a   Nordbø, Svein Arne ^b   Skjeldestad, Finn Egil ^a  

^a SINTEF   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GENITAL TRACT INFECTION; HUMAN; INCIDENCE; MALE; NORWAY; PREVALENCE; REGISTER;

ADOLESCENT; ADULT; AGE FACTORS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; NORWAY; PREVALENCE; REGISTRIES; SEX FACTORS;

EID: 29944434275     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000187929.36118.d2     Document Type: Article

References (27)

1. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004; 80:255-263.
2. Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ 2000; 320:916-919.
3. Weström L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
4. LaMontagne DS, Patrick LE, Fine DN, et al. Re-evaluating selective screening criteria for chlamydial infection among women in the US Pacific Northwest. Sex Transm Dis 2004; 31:283-289.
5. LaMontagne DS, Fine DN, Marrazzo JM. Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med 2003; 24:36-42.
6. LaMontagne DS, Fenton KA, Randall S, et al. Establishing the National Chlamydia Screening Programme in England: Results from the first full year of screening. Sex Transm Infect 2004; 80:335-341.
7. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2003 Supplement, Chlamydia Prevalence Monitoring Project. Atlanta: US Department of Health and Human Services, Centers of Disease Control and Prevention, October 2004.
8. Bauer HM, Chartier M, Kessell E, et al. Chlamydia screening of youth and young adults in non-clinical settings throughout California. Sex Transm Dis 2004; 31:409-414.
9. McKay L, Clery H, Carrick-Anderson K, et al. Genital Chlamydia trachomatis infection in a subgroup of young men in the UK. Lancet 2003; 361:1792.
10. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229-2236.
11. Powell J, O'Connor C, O'hlarlaithe M, et al. Chlamydia trachomatis prevalence in men in the mid-west of Ireland. Sex Transm Infect 2004; 80:349-353.
12. Vuylsteke B, Vandenbruaene M, Vandenbalcke P, et al. Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm Infect 1999; 75:152-155.
13. Levine WC, Dicker LW, Devine O, et al. Indirect estimation of chlamydia screening coverage using public health surveillance data. Am J Epidemiol 2004; 160:91-96.
14. Kufeji O, Slack R, Cassell JA, et al. Who is being tested for genital chlamydia in primary care? Sex Transm Infect 2003; 79:234-236.
15. Møller JK, Andersen B, Olesen F, et al. Reasons for Chlamydia trachomatis testing and the associated age-specific prevalences. Scand J Clin Lab Invest 2003; 63:339-345.
16. Chlamydia screening among sexually active young female enrollees of health plans - United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2004; 53:983-985.
17. Burstein GR, Snyder MH, Conley D, et al. Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis 2001; 28:477-483.
18. Aavitsland P. Use of laboratory testing for genital chlamydial infection in Norway. Qual Health Care 1993; 2:91-95.
19. Pedersen W, Samuelsen SO. Nye mønstre av seksualatferd blant ungdom [in Norwegian]. Tidsskr Nor Lægeforen 2003; 123:3006-3009.
20. Dicker LW, Mosure DJ, Levine WC, et al. Impact of switching laboratory tests on reported trends in Chlamydia trachomatis infections. Am J Epidemiol 2000; 151:430-435.
21. Schillinger JA, Dunne EF, Chapin JB, et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 US cities. Sex Transm Dis 2005; 32:74-77.
22. Vincelette J, Schirm J, Bogard M, et al. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1999; 37:74-80.
23. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: Reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001; 358:1851-1854.
24. Kent CK, Chaw JK, Kohn RP, et al. Studies relying on passive retrospective cohorts developed from health services data provide biased estimates of incidence of sexually transmitted infections. Sex Transm Dis 2004; 31:596-600.
25. Honey E, Augood C, Templeton A, et al. Cost effectiveness of screening for Chlamydia trachomatis: A review of published studies. Sex Transm Infect 2002; 78:406-412.
26. Ginocchio RH, Veenstra DL, Connell FA, et al. The clinical and economic consequences of screening young men for genital chlamydial infection. Sex Transm Dis 2003; 30:99-106.
27. Valkengoed van IG, Morre SA, Brule van den AJC, et al. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes - implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33:416-425.